Dual activity of triterpenoids: Apoptotic versus antidifferentiation effects

Archives of Toxicology

Volumn 80, Issue 7, 2006, Pages 429-435

  Cipak, Lubos ^a   Grausova, Lubica ^b   Miadokova, Eva ^b   Novotny, Ladislav ^c   Rauko, Peter ^a  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antioxidant; Apoptosis; Differentiation; Doxorubicin; Triterpenoid

Indexed keywords

DOXORUBICIN; OLEANOLIC ACID; TRITERPENOID; URSOLIC ACID;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DOXORUBICIN; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LEUKEMIA L1210; LEUKEMIA, MYELOID, CHRONIC; MICE; OLEANOLIC ACID; TRITERPENES;

EID: 33745056480     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-006-0072-6     Document Type: Article

References (31)

1. Anderson RD, Berger NA (1994) International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat Res 309:109-142
2. Carmichael J, Degraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of tetrazolium-based semiautomated colorometric assays: assessment of chemisensitivity testing. Cancer Res 47:936-942
3. Chenais B, Andriollo M, Guiraud P, Belhoussine R, Jeannesson P (2000) Oxidative stress involvement in chemically induced differentiation of K562 cells. Free Radic Biol Med 28:18-27
4. Choi YH, Baek JH, Yoo MA, Chung HY, Kim ND, Kim KW (2000) Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells. Int J Oncol 17:565-571
5. Chou TC, Talalay P (1983) Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol Sci 4:450-455
6. Cipak L, Novotny L, Cipakova I, Rauko P (2003a) Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids. Nutr Res 23:1045-1057
7. Cipak L, Rauko P, Miadokova E, Cipakova I, Novotny L (2003b) Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells. Leuk Res 27:65-72
8. Courage C, Budworth J, Gescher A (1995) Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localization. Br J Cancer 71:697-704
9. Debes A, Oerding M, Willers R, Gobel U, Wessalowski R (2003) Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin. Anticancer Res 23:3359-3366
10. Evans DL, Tilby M, Dive C (1994) Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res 54:1596-1603
11. Fernandes J, Castilho RO, da Costa MR, Wagner-Souza K, Kaplan MAC, Gattass CR (2003) Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett 190:165-169
12. Heo HJ, Cho HY, Hong B, Kim HK, Heo TR, Kim EK, Kim SK, Kim CJ, Shin DH (2002) Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury. Mol Cells 13:5-11
13. Ikeda T, Sporn M, Honda T, Gribble GW, Kufe D (2003) The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance. Cancer Res 63:5551-5558
14. Jeannesson P, Lahlil R, Chenais B, Devy L, Gillet R, Aries A, Morceau F, Trentesaux C (1997) Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression. Leuk Lymphoma 26:575-587
15. Jeong HG, Kim HG, Hwang YP (2005) Involvement of cytokines in the hepatic expression of metallothionein by ursolic acid. Toxicol Lett 155:369-376
16. Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S (2004) Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci 74:2769-2779
17. Lauthier F, Taillet L, Trouillas P, Delage C, Simon A (2000) Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs 11:737-745
18. Lee HY, Chung HY, Kim KH, Lee JJ, Kim KW (1994) Induction of differentiation in cultured F9 teratocarcinoma stem-cells by triterpene acids. J Cancer Res Clin Oncol 120:513-518
19. Liu F, Ng TB (2000) Antioxidative and free radical scavenging activities of selected medicinal herbs. Life Sci 66:725-735
20. Nyoung MN, Trentesaux C, Aries A, Carpentier Y, Jardillier JC, Gorisse MC, Jeannesson P (1994) Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Anticancer Res 14:1203-1208
21. Oguro T, Liu J, Klaassen CD, Yoshisa T (1998) Inhibitory effect of oleanolic acid on 12-O-tetradecanoylphorbol-13-acetate-induced gene expression in mouse skin. Toxicol Sci 45:88-93
22. Ovesna Z, Vachalkova A, Horvathova K, Tothova D (2004) Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma 51:327-333
23. Pan D, Qin J, Farber C, O'Brien J, Filippa D, Portlock CS (2003) CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas. Leuk Lymphoma 44:967-971
24. Peng L, Wang B, Ren P (2005) Reduction of MTT by flavonoids in the absence of cells. Colloid Surface B 45:108-111
25. Scalbert A, Manach C, Morand C, Remesy C, Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287-306
26. Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30:1191-1212
27. Somova LO, Nadar A, Rammanan P, Shode FO (2003) Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 10:115-121
28. Suh WS, Kim YS, Schimmer AD, Kitada S, Minden M, Andreeff M, Suh N, Sporn M, Reed JC (2003) Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL. Leukemia 17:2122-2129
29. Szekeres T, Fritzer M, Strobl H, Gharehbaghi K, Findenig G, Elford HL, Lhotka C, Schoen HJ, Jayaram HN (1994) Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells. Blood 84:4316-4321
30. Tagashira M, Ohtake Y (1998) A new antioxidative 1,3-benzodioxole from Melissa officinalis. Planta Med 64:555-558
31. Visani G, Guiducci B, D'Adamo F, Mele A, Nicolini G, Leopardi G, Sparaventi G, Barulli S, Malerba L, Isidori A, Malagola M, Piccaluga PP (2005) Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma. Leuk Lymphoma 46:477-479